sport.wikisort.org - Athlete
William B. Harrison Jr., (born August 12, 1943), in Rocky Mount, North Carolina, is the former CEO and chairman of JPMorgan Chase. He attended high school at Virginia Episcopal School, where he was a basketball star. He attended the University of North Carolina at Chapel Hill, where he was admitted to the Zeta Psi fraternity. Having risen through the ranks of Chemical Bank before succeeding Walter V. Shipley during the Chemical Bank merger with the Chase Manhattan Corporation in 1995, which kept the Chase name. As Chairman and CEO of Chase, he and Douglas A. Warner III, then CEO of J.P. Morgan & Co., were the principal architects of the US$30.9 billion acquisition by Chase of J.P. Morgan & Co. in 2000, to form JPMorgan Chase & Co.[1] Harrison has been a director of the Firm or a predecessor institution since 1991. Harrison is also a director of Merck & Co., Inc.
| This article needs additional citations for verification. (February 2020) |
Jamie Dimon, former Bank One CEO, replaced Harrison as chairman on January 1, 2007,[2] following Harrison's decision to step down from his chairman position of JPMorgan on December 31, 2006.
Resume
- A.B. degree in economics from the University of North Carolina
- Graduate of the Harvard Business School's International Senior Management Programme in Switzerland
Director since 1991 of JPMorgan Chase or a predecessor institution:
- Vice chairman of the board of The Chase Manhattan Corporation, 1991 through June 1999
- President and chief executive officer of The Chase Manhattan Corporation, June through Dec. 1999
- Chairman and chief executive officer of The Chase Manhattan Corporation, Jan. 2000 through its merger with J.P. Morgan & Co. Incorporated, in Dec. 2000
- President and chief executive officer of JPMorgan Chase, Dec. 2000 through Nov. 2001
- Chairman and chief executive officer of JPMorgan Chase, Nov. 2001 through Dec. 2005
- Became chairman of JPMorgan Chase on December 31, 2005
[3]
References
Business positions |
Preceded by Walter V. Shipley |
Chase CEO 1999 |
Succeeded by Merged with JP Morgan to become JP Morgan Chase |
Preceded by Chase and J.P. Morgan merged to form company 2000 |
JPMorgan Chase CEO 2000–2005 |
Succeeded by Jamie Dimon |
Merck & Co., Inc. |
---|
Corporate directors: |
- Richard Clark
- Johnnetta Cole
- William Harrison
- William Kelley
- Rochelle Lazarus
- Thomas Shenk
- Anne Tatlock
- Samuel Thier
- Wendell Weeks
- Peter Wendell
|
---|
Subsidiaries: |
- Acceleron Pharma
- Cubist Pharmaceuticals
- H. K. Mulford Company
- Schering-Plough
- Viralytics
|
---|
Products: |
- Alendronate
- Aprepitant
- Ertapenem
- Ezetimibe
- Ezetimibe/simvastatin
- Finasteride
- Fosaprepitant
- Indinavir
- Losartan
- Lovastatin
- Montelukast
- Omarigliptin
- Raltegravir
- Rizatriptan
- Rofecoxib
- rVSV-ZEBOV vaccine
- Simvastatin
- Sitagliptin
- Vericiguat
- Vorinostat
Schering-Plough: |
- Coppertone sign
- Desloratadine
- Ezetimibe
- Ezetimibe/simvastatin
- Famciclovir
- Infliximab
- Loratadine
- Mometasone
- Rocuronium bromide
- Temozolomide
- Tibolone
- Urofollitropin
|
---|
|
---|
Facilities: |
- Merck Headquarters Building
|
---|
Publications: |
- Merck Manual of Diagnosis and Therapy
- The Merck Manuals
- Index
- Manual
- Veterinary
- Geriatrics
|
---|
Текст в блоке "Читать" взят с сайта "Википедия" и доступен по лицензии Creative Commons Attribution-ShareAlike; в отдельных случаях могут действовать дополнительные условия.
Другой контент может иметь иную лицензию. Перед использованием материалов сайта WikiSort.org внимательно изучите правила лицензирования конкретных элементов наполнения сайта.
2019-2025
WikiSort.org - проект по пересортировке и дополнению контента Википедии